Group | Frequentist Modelling

The group operates the data centre of the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA). It develops models for studying the long-term effects of air pollution on population health, and supports and supervises analyses conducted within SAPALDIA.
The group conducts time-series modelling of the short-term effects of air pollution and also contributes to the development of spatio-temporal models of air pollutants in Switzerland. Moreover, the group is linked to clinical research projects, notably in neurology, and specialised in supporting clinically oriented projects within the Swiss TPH data team. The group runs statistics courses for the medical curriculum and administers two master level courses in the Faculty of Science and in two postgraduate courses.
Selected Projects
All ProjectsLatest Publications
All PublicationsBrown J.A et al. Dolutegravir in real life: self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho. HIV Med. 2023;24(2):153-162. DOI: 10.1111/hiv.13352
Castillo-Mancilla J.R et al. Beyond undetectable: modeling the clinical benefit of improved antiretroviral adherence in persons with human immunodeficiency virus with virologic suppression. Open Forum Infect Dis. 2023;10(5):ofad230. DOI: 10.1093/ofid/ofad230
Kalinjuma A.V et al. Body mass index trends and its impact of under and overweight on outcome among PLHIV on antiretroviral treatment in rural Tanzania: a prospective cohort study. PLoS One. 2023;18(8):e0290445. DOI: 10.1371/journal.pone.0290445
Katende B et al. Impact of a multi-disease integrated screening and diagnostic model for COVID-19, TB, and HIV in Lesotho. PLOS Glob Public Health. 2023;3(8):e0001488. DOI: 10.1371/journal.pgph.0001488
Kopo M et al. Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: the PEBRA cluster-randomized trial. PLoS Med. 2023;20(1):e1004150. DOI: 10.1371/journal.pmed.1004150